Schizophrenia Trial, Recruiting NCT07419321 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07419321
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with schizophrenia or a related condition:

  • You have been diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or a similar condition (but not a psychotic disorder caused only by substance use)
  • You are between 40 and 70 years old at the time of joining the study
  • You took part in a previous research study when you were between 20 and 55 years old, and that study happened at least 5 years ago
  • You are able to understand the spoken language used in the country where the study is taking place well enough to follow the test instructions
  • You have been mentally stable recently — meaning no hospital stays in the past 3 months and no changes to your medication in the past 4 weeks

For siblings of people with schizophrenia:

  • You do not have a diagnosis of a serious mental health condition known to affect social functioning (such as severe mood disorder, schizoaffective personality disorder, or autism spectrum disorder)
  • You are between 40 and 70 years old at the time of joining the study
  • You took part in a previous research study when you were between 20 and 55 years old, and that study happened at least 5 years ago
  • You are able to understand the spoken language used in the country where the study is taking place well enough to follow the test instructions
  • You have been stable recently — meaning no hospital stays in the past 3 months and no changes to your medication in the past 4 weeks

Who may not be able to join:

  • You have a history of a serious head injury where you were unconscious for more than 1 hour, had lasting effects on thinking or memory, or received cognitive rehabilitation treatment after the injury
  • You have a history of an IQ below 70 or a developmental disability (based on medical records)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Abraham Reichenberg, Icahn School of Medicine at Mount Sinai

Phone: +31618644345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 January 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇳🇱 Netherlands 🇪🇸 Spain 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Occurrence of newly diagnosed conditions; Short Form Health Survey (SF-36),; Number of Participants with High Cholesterol; Number of participants with High Blood Pressure; Schedule for Deficit Syndrome (SDS); The Birchwood social functioning scale (SFS); 'Social Isolation' subscale of the Structured Interview for Schizotypy-Revised (SIS-R)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov